Table 1. Overview of FDA approved and/or CE certified intragastric balloons in alphabetic order.
| Balloon type | Implant/explant | FDA approved | CE mark | Time in situ (months) | Filling | Volume (mL) | TBWL (%) | EWL (%) | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| Elipse® | Swallow/excretion | No* | Yes | 4 | Liquid | 450–550 | 10.0 | n/a | (4) |
| End-Ball® | Endo/endo | No | Yes | 6 | Liquid/gas | 700 | 17.1 | 36.5 | (5) |
| Heliosphere® BAG | Endo/endo | No | Yes | 6 | Air | 700 | 13.4 | 33.2 | (6) |
| Lexbal® | Endo/endo | No | Yes | 6 | Liquid | 500–800 | 14.9 | 26.8 | (7) |
| MedSil® | Endo/endo | No | Yes | 6 | Liquid | 400–700 | 13.1 | n/a | (8) |
| Obalon® | Swallow/endo | Yes | Yes | 6 | Gas | 3×250 | 7.1 | n/a | (9) |
| Orbera® | Endo/endo | Yes | Yes | 6 | Liquid | 400–700 | 10.2 | 26.5 | (10) |
| Reshape® | Endo/endo | Yes | Yes | 6 | Liquid | 750–900 | 6.8 | 25.1 | (11) |
| Spatz3® | Endo/endo | No | Yes | 12 | Liquid | Adjustable | 20.1 | 45.8 | (12) |
*, in progress. FDA, Food and Drug Administration; CE, Communauté Européenne; TBWL, total body weight loss; EWL, excess weight loss; endo, endoscopically; n/a, not applicable.